Coming soon: Predictive analytics for adult kidney offers
The goal is to help decision makers make evidence-based decisions to benefit candidates when determining whether to accept or refuse an offer.
The goal is to help decision makers make evidence-based decisions to benefit candidates when determining whether to accept or refuse an offer.
The new formula for Calculated Panel Reactive Antibody (CPRA) will now go into effect on Jan. 26, 2023.
Kidney programs should update candidate data ahead of Dec. 15 final implementation.
This will also include a conversion of each transplant hospital’s MMaT score to reflect transplants performed at hospitals within a radius of 250 miles.
We implemented phase 1 system changes on July 29. Phase 2 policy and system changes will be effective September 5.
Access the updated report from the data services portal in UNet.